- Home
- COGT vs AWF Comparison
COGT vs AWF Comparison
Compare COGT & AWF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- AWF
- Stock Information
- Founded
- COGT 2014
- AWF 1993
- Country
- COGT United States
- AWF United States
- Employees
- COGT N/A
- AWF N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- AWF Trusts Except Educational Religious and Charitable
- Sector
- COGT Health Care
- AWF Finance
- Exchange
- COGT Nasdaq
- AWF Nasdaq
- Market Cap
- COGT 1.0B
- AWF 928.7M
- IPO Year
- COGT 2018
- AWF N/A
- Fundamental
- Price
- COGT $6.48
- AWF $10.73
- Analyst Decision
- COGT Buy
- AWF
- Analyst Count
- COGT 7
- AWF 0
- Target Price
- COGT $14.17
- AWF N/A
- AVG Volume (30 Days)
- COGT 1.0M
- AWF 190.0K
- Earning Date
- COGT 05-06-2025
- AWF 01-01-0001
- Dividend Yield
- COGT N/A
- AWF 7.57%
- EPS Growth
- COGT N/A
- AWF N/A
- EPS
- COGT N/A
- AWF N/A
- Revenue
- COGT N/A
- AWF N/A
- Revenue This Year
- COGT N/A
- AWF N/A
- Revenue Next Year
- COGT N/A
- AWF N/A
- P/E Ratio
- COGT N/A
- AWF N/A
- Revenue Growth
- COGT N/A
- AWF N/A
- 52 Week Low
- COGT $5.88
- AWF $9.20
- 52 Week High
- COGT $12.61
- AWF $10.67
- Technical
- Relative Strength Index (RSI)
- COGT 38.02
- AWF 44.58
- Support Level
- COGT $6.31
- AWF $10.74
- Resistance Level
- COGT $7.49
- AWF $10.84
- Average True Range (ATR)
- COGT 0.43
- AWF 0.09
- MACD
- COGT -0.04
- AWF 0.01
- Stochastic Oscillator
- COGT 10.90
- AWF 71.25
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
About AWF Alliancebernstein Global High Income Fund
Alliancebernstein Glb High Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its primary investment objective is to seek high current income, and secondarily, capital appreciation. The fund invests in the debt securities, including Sovereign Debt Obligations and corporate debt, denominated in non-U.S. currencies as well as in the U.S. Dollar. It may invest without limit in emerging and developed markets and debt securities of U.S. and non-U.S. corporate issuers.